RalB Antibody (OTI2C4) [CoraFluor™ 1]
Novus Biologicals, part of Bio-Techne | Catalog # NBP2-73785CL1
Key Product Details
Species Reactivity
Applications
Label
Antibody Source
Concentration
Product Specifications
Immunogen
Reactivity Notes
Clonality
Host
Isotype
Description
CoraFluor(TM) 1, amine reactive
CoraFluor(TM) 1, thiol reactive
For more information, please see our CoraFluor(TM) TR-FRET technology flyer.
Scientific Data Images for RalB Antibody (OTI2C4) [CoraFluor™ 1]
Product Feature: CoraFluor Probes for TR-FRET
CoraFluor™ 1, amine reactive (Catalog:7920) and CoraFluor™ 2, amine reactive (Catalog # 7950) are terbium-based probes that have been developed for use as TR-FRET donors. They emit wavelengths compatible with commonly used fluorescent acceptor dyes such as BODIPY® (or BDY) and Janelia Fluor® dyes, FITC (Catalog # 5440), TMR and Cyanine 5 (Catalog # 5436). CoraFluor™ fluorescence is brighter and more stable in biological media than existing TR-FRET donors, leading to enhanced sensitivity and improved data generation. CoraFluor™ 1 exhibits excitation upon exposure to a 337 nm UV laser.Applications for RalB Antibody (OTI2C4) [CoraFluor™ 1]
Immunocytochemistry/ Immunofluorescence
Immunohistochemistry
Immunohistochemistry-Paraffin
Western Blot
Formulation, Preparation, and Storage
Purification
Formulation
Preservative
Concentration
Shipping
Stability & Storage
Background: RalB
The Ras-like proteins RalA and RalB are homologous proteins that constitute a grouping within the Ras superfamily of small GTPases. Like other GTPases, Ral protein activity is regulated by cycling between an active GTP-bound and an inactive GDP-bound state. Ral GTPases have been implicated in the regulation of vesicle trafficking and cell morphology.
Long Name
Alternate Names
Gene Symbol
Additional RalB Products
Product Documents for RalB Antibody (OTI2C4) [CoraFluor™ 1]
Product Specific Notices for RalB Antibody (OTI2C4) [CoraFluor™ 1]
CoraFluor (TM) is a trademark of Bio-Techne Corp. Sold for research purposes only under agreement from Massachusetts General Hospital. US patent 2022/0025254
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.